LRRK2 and Parkinson disease: For example, LRRK2-PD patients exhibit less α-synuclein aggregation in Cerebrospinal Fluid (CSF), feature that is a hallmark of sPD29,30 as well as increased basal forebrain volume, which is probably a compensation of the cholinergic system31.